This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Arcus Biosciences, Inc., Other. Active years: 1994-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1994-2025
Title: Innovations in Cancer Treatment by Stephen W Young
Introduction
Stephen W Young is a notable inventor based in Palomar Park, California. He has made significant contributions to the field of oncology, particularly in the treatment of oncogene-driven cancers. With a total of 3 patents to his name, Young's work focuses on innovative methods to combat cancer through targeted therapies.
Latest Patents
Young's latest patents include groundbreaking methods for treating oncogene-driven cancers. One of his patents outlines a treatment approach that involves administering agents that target the extracellular production of adenosine and antagonize the activation of adenosine receptors. Another patent details methods for treating cancer by utilizing an established adenosine fingerprint, which includes assessing the blood concentration and enzymatic activity of adenosine machinery proteins. These methods aim to provide more effective therapeutic options for patients suffering from cancer.
Career Highlights
Throughout his career, Stephen W Young has worked with various organizations, including Arcus Biosciences, Inc. His experience in the biotechnology sector has allowed him to develop and refine his innovative approaches to cancer treatment. Young's dedication to advancing medical science is evident in his research and patent filings.
Collaborations
Young has collaborated with notable colleagues in his field, including Akshata R Udyavar and Amy Elizabeth Anderson. These partnerships have contributed to the development of his innovative cancer treatment methods.
Conclusion
Stephen W Young's contributions to cancer treatment through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative approaches continue to pave the way for advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile